Investition von ca. 8,5 Millionen USD in Malaria- und NTD-Forschungsprojekte mit Partnern wie MMV, GSK und DNDi.

Quelle: PR Newswire
Link: https://www.prnewswire.com/news-releases/total-investment-of-approx-usd-8-5-million-in-malaria-and-ntd-rd-projects-with-partners-including-mmv-gsk-tanabe-pharma-eisai-and-dndi-302748056.html